Details of the Drug Reposition

General Information of This Drug (ID: DM804UR)

• Drug Name: Hyoscyamine (DM804UR)
• Synonyms: L-Hyoscyamine; hyoscyamine; 101-31-5; (-)-Hyoscyamine; Daturine; Duboisine; (-)-Atropine; L-Tropine tropate; (S)-Atropine; (S)-(-)-Hyoscyamine; Hyoscyamine (L); UNII-PX44XO846X; Tropine, (-)-tropate; Levbid; PX44XO846X; Levsinex SR; CHEBI:17486; Hyoscyamine, l-; [3(S)-endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[321]oct-3-yl ester; (2S)-(1R,5S)-8-Methyl-8-azabicyclo[321]octan-3-yl 3-hydroxy-2-phenylpropanoate; (1R,5S)-8-METHYL-8-AZABICYCLO[321]OCT-3-YL (2R)-3-HYDROXY-2-PHENYLPROPANOATE; Hyocyamine
• Therapeutic Class: Antiarrhythmic Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

5 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Vernal keratoconjunctivitis	DIS36LV6	N.A.	Approved	[1]
Sick sinus syndrome 2, autosomal dominant	DIS0UITQ	N.A.	Approved	[1]
Peptic ulcer	DISL8XZI	DA61	Approved	[2]
Gastrointestinal disease	DIS7JDYJ	DE2Z	Approved	[3]
Dysuria	DIS7ZXDJ	MF50.7	Approved	[1]

References

• [1] A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
• [2] Clinical significance of M1 receptor antagonists. Pharmacology. 1988;37 Suppl 1:54-63.
• [3] Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313.